Notice for pralsetinib (Roche Products Pty Limited)
Active ingredients
pralsetinib
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Oncology
This webpage on the TGA website was printed on 10 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/designations-determinations/notice-pralsetinib-roche-products-pty-limited-0